Catalyst Wire Dossier Catalyst Wire Dossier

Nano-COVID19

methotrexate associated to LDL-like nanoparticles · University of Sao Paulo General Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nano-COVID19, covering 2021-01-14 to 2021-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) [Phase 1, Phase 2]

See pricing